Aggressive UVB Light Skin Treatment Leaves Man With Severe Burns

ByMichael Talve, CEO

|

Updated on

Aggressive UVB Light Skin Treatment Leaves Man With Severe Burns

This case involves a 60-year-old male patient with a past medical history of diabetes, heart disease, and kidney disease. He was being seen by a dermatologist for itchy, bleeding lesions affecting both temples and upper cheeks for a one-month duration. These lesions were described to be excoriated plaques and the working diagnosis was that of neurodermatitis. Lidex was prescribed twice daily at this point with a follow up in three weeks. Upon follow-up, the condition improved somewhat but the lesions were still present which prompted the physician to perform a biopsy. His dermatologist then recommended light therapy to heal the lesions. The patient started ultraviolet light (UVB) phototherapy room treatment for 1.5 minutes with 30-second increases, every week as tolerated. After several months of treatment, the patient complained of a red and painful burning sensation on his face which was described by the physician as a possible photo-derm reaction.

Question(s) For Expert Witness

1. Are you familiar with a case such as this and can you speak on the protocol involved in using UVB light for the treatment of skin disorders and also what complications are considered to be beyond that of common occurrences?

2. Also should the physician have noticed the reaction and stopped the successive light therapy sessions?

Expert Witness Response E-001270

inline imageI have over 30 years experience with UVB therapy. Without knowing the results of the biopsy, the nature of the rash and particulars of the patient care provided I can't give a detailed opinion but what I can say is that one can experience many adverse side effects from this type of therapy and the physician should always be cautious in the initial administration period. The procedure should be done in a step up fashion to see if the patient can tolerate the abrasive effects of the UVB photo wavelengths. If no irritation is present after low doses then the therapy may be increased accordingly, but it seems the physician may have been too aggressive in his primary treatment phase.

About the author

Michael Talve, CEO

Michael Talve, CEO

Michael Talve stands at the forefront of legal innovation as the CEO and Managing Director of Expert Institute. Under his leadership, the Expert Institute has established itself as a vital player in the legal technology arena, revolutionizing how lawyers connect with world-class experts and access advanced legal technology. Michael's role involves not only steering the company's strategic direction but also ensuring the delivery of unparalleled intelligence and cutting-edge solutions to legal professionals. His work at Expert Institute has been instrumental in enhancing the capabilities of attorneys in case preparation and execution, making a significant impact on the legal industry's approach to expert consultation and technological integration. Michael's vision and execution have positioned the Expert Institute as a key facilitator in the intersection of law and technology.

Find an expert witness near you

What State is your case in?

What party are you representing?

background image

Subscribe to our newsletter

Join our newsletter to stay up to date on legal news, insights and product updates from Expert Institute.